FDA Qualified PROWL-SS Tool for Evaluating LASIK Devices

The tool provides critical patient-reported outcomes data about vision symptoms and satisfaction with vision after LASIK surgery.

If your email program has trouble displaying this email, view as a webpage. FDA Qualified the PROWL-SS Medical Device Development Tool for Developing and Evaluating LASIK Devices The U.S. Food and Drug Administration (FDA) qualified the Patient-Reported Outcomes with LASIK Symptoms and Satisfaction (PROWL-SS) tool through the Medical Device Development Tools (MDDT) program. PROWL-SS provides patients, eye-care providers, and manufacturers with valuable information about important patient-reported vision symptoms and their level of satisfaction with vision after LASIK surgery. Read More This tool will support the FDA's premarket and post-market regulatory decision making and can be used by manufacturers for the evaluation of LASIK devices. Questions? If you have questions about the MDDT Program, contact MDDT@fda.hhs.gov.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA